Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00906217
Other study ID # Hookey Picosalax Elderly Trial
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 2009
Est. completion date September 2011

Study information

Verified date April 2024
Source Queen's University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study aims to further define the appropriate population for Pico-Salax, a purgative used prior to colonoscopy. Patients over the age of 70 years with normal renal function scheduled for colonoscopy will receive Pico-Salax and have pre and post preparation bloodwork and electrocardiograms (ECGs).


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date September 2011
Est. primary completion date July 2010
Accepts healthy volunteers No
Gender All
Age group 70 Years and older
Eligibility Inclusion Criteria: - >70 years Exclusion Criteria: - renal dysfunction - congestive heart failure - ileus

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Queen's University

Outcome

Type Measure Description Time frame Safety issue
Primary serum electrolyte changes pre and post preparation 2 months
See also
  Status Clinical Trial Phase
Completed NCT02254486 - Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus Trisulfate Solution Using 2-Day Split-Dosing Regimen in Adults Phase 3
Recruiting NCT00981539 - Will Cleaning the Bowel With an Enema Before Vaginal Prolapse Surgery Prevent Complications? N/A
Recruiting NCT00748293 - Achievement of Better Examinee Compliance on Colon Cleansing Using Commercialized Low-Residue Diet N/A
Completed NCT01427296 - Safety and Efficacy of OsmoPrep® Tablets Versus HalfLytely® and Bisacodyl Tablet Bowel Prep Kit for Colon Cleansing Phase 4
Completed NCT02273167 - Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus MOVIPREP® Using 2-Day Split-Dosing and 1-Day Morning Split-Dosing Regimen in Adults. Phase 3
Completed NCT05174845 - Real Word Evidence With 1L Polyethylene Glycol (PEG)+ Ascorbic Acid in Iberia
Completed NCT02273141 - Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus a Sodium Picosulfate and Magnesium Salt Solution Using Day Before-Only Dosing Regimen in Adults. Phase 3
Completed NCT01840553 - Efficacy and Safety Study of Sodium Phosphate Tablets vs PEG for Bowel Cleansing Phase 3
Completed NCT01909219 - PMC Split Preparation for Colon Cleansing Phase 4